Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX-629 in mild atopic asthma
NCT04728711Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acloproxalap, sponsored by Aldeyra Therapeutics. Started Jan 2021; status: completed.
02
Drugs
acloproxalap
Beyond the preview
Go deeper on NCT04728711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728711.